A Genome-Wide Association Study Identifies Novel Susceptibility loci in Chronic Chagas Cardiomyopathy.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
16 08 2021
Historique:
received: 04 12 2020
accepted: 01 02 2021
pubmed: 5 2 2021
medline: 23 9 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

Chagas disease is an infectious disease caused by the parasite Trypanosoma cruzi and is endemic from Latin American countries. The goal of our study was to identify novel genetic loci associated with chronic Chagas cardiomyopathy development in Chagas disease patients from different Latin American populations. We performed a cross-sectional, nested case-control study including 3 sample collections from Colombia, Argentina, and Bolivia. Samples were genotyped to conduct a genome-wide association study (GWAS). These results were meta-analyzed with summary statistic data from Brazil, gathering a total of 3413 Chagas disease patients. To identify the functional impact of the associated variant and its proxies, we performed an in silico analysis of this region. The meta-analysis revealed a novel genome-wide statistically significant association with chronic Chagas cardiomyopathy development in rs2458298 (OR = 0.90, 95%CI = 0.87-0.94, P-value = 3.27 × 10-08), nearby the SAC3D1 gene. In addition, further in silico analyses displayed functional relationships between the associated variant and the SNX15, BAFT2, and FERMT3 genes, related to cardiovascular traits. Our findings support the role of the host genetic factors in the susceptibility to the development of the chronic cardiac form of this neglected disease.

Sections du résumé

BACKGROUND
Chagas disease is an infectious disease caused by the parasite Trypanosoma cruzi and is endemic from Latin American countries. The goal of our study was to identify novel genetic loci associated with chronic Chagas cardiomyopathy development in Chagas disease patients from different Latin American populations.
METHODS
We performed a cross-sectional, nested case-control study including 3 sample collections from Colombia, Argentina, and Bolivia. Samples were genotyped to conduct a genome-wide association study (GWAS). These results were meta-analyzed with summary statistic data from Brazil, gathering a total of 3413 Chagas disease patients. To identify the functional impact of the associated variant and its proxies, we performed an in silico analysis of this region.
RESULTS
The meta-analysis revealed a novel genome-wide statistically significant association with chronic Chagas cardiomyopathy development in rs2458298 (OR = 0.90, 95%CI = 0.87-0.94, P-value = 3.27 × 10-08), nearby the SAC3D1 gene. In addition, further in silico analyses displayed functional relationships between the associated variant and the SNX15, BAFT2, and FERMT3 genes, related to cardiovascular traits.
CONCLUSIONS
Our findings support the role of the host genetic factors in the susceptibility to the development of the chronic cardiac form of this neglected disease.

Identifiants

pubmed: 33539531
pii: 6128793
doi: 10.1093/cid/ciab090
pmc: PMC8366831
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

672-679

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268200417175C
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI098461
Pays : United States
Organisme : Red Iberoamericana de medicina genómica en enfermedad de Chagas
ID : RIMGECH-217RT0524
Organisme : CYTED
Organisme : Ministerio de Ciencia y Tecnología de Córdoba
ID : PID 2018
Organisme : Secretaría de Ciencia y Tecnología
ID : 2018-2021
Organisme : NIAID NIH HHS
ID : P50 AI098461
Pays : United States
Organisme : CNPq
ID : 310679/2016-8
Organisme : FAPEMIG
ID : PPM-00428-17
Organisme : NHLBI NIH HHS
Pays : United States
Organisme : Agence Nationale de Recherche

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Desiré Casares-Marfil (D)

Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.

Mariana Strauss (M)

Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis, FCM, INICSA-CONICET-UNC, Córdoba, Argentina.

Pau Bosch-Nicolau (P)

Unidad de Medicina Tropical y Salud Internacional Hospital Universitari Vall d'Hebron, PROSICS, Barcelona, Spain.

María Silvina Lo Presti (MS)

Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis, FCM, INICSA-CONICET-UNC, Córdoba, Argentina.

Israel Molina (I)

Unidad de Medicina Tropical y Salud Internacional Hospital Universitari Vall d'Hebron, PROSICS, Barcelona, Spain.

Christophe Chevillard (C)

INSERM, Aix Marseille university, TAGC, UMR_1090, Marseille, France.

Edecio Cunha-Neto (E)

Laboratory of Immunology, Heart Institute (InCor)/Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Ester Sabino (E)

Instituto de Medicina Tropical Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Antonio Luiz P Ribeiro (ALP)

Centro de Telessaúde, Hospital das Clínicas, Belo Horizonte, Brazil.
Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Clara Isabel González (CI)

Grupo de Inmunología y Epidemiología Molecular, Escuela de Microbiología, Universidad Industrial de Santander, Bucaramanga, Colombia.

Javier Martín (J)

Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.

Marialbert Acosta-Herrera (M)

Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH